Search Results for: CRISPR
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
FDA Approves A CRISPR-Based Therapy for Sickle Cell Disease
2023-12-12
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
Nucleate Taiwan Launched: Pivot of International Bioindustry
2023-10-11
Sanofi Inks Two Major Strategic R&D Collaborations in a Single Week
2023-07-24
GeneOnline’s Weekly News Highlights: July 17-21
2023-07-24
Re-engineered Bacterial “Syringes” for Programmable Protein Delivery
2023-04-06
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Developments in Regenerative Medicine: Gene Delivery Tools and Cell Therapy for Parkinson’s Disease
2023-03-08
Patent Landscape Analysis of Gene Therapy
2023-02-08
1 2 3 16
Scroll to Top